Evran Sedat
EVRAN SEDAT, EVP, GSC, reported a transaction classified as exercise at BIO-RAD LABORATORIES, INC. involving 1044.000000 shares for an estimated $0.00. Reported holdings after the transaction were 1044.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 20, 2026
- Filing date
- Oct 22, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BIO BIO.B price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001993147-26-000004 Restricted Stock Units
- Transaction date
- Oct 20, 2026 Filed Oct 22, 2026, 09:55 PM · 2d delay
- Shares
- 1,044 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 1,044 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP, Global Supply Chain
- F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3
On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
0 other transactions
0 recent txs